Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11364
Title: Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Austin Authors: Packham, David K;Alves, Tahira P;Dwyer, Jamie P;Atkins, Robert;de Zeeuw, Dick;Cooper, Mark E;Shahinfar, Shahnaz;Lewis, Julia B;Lambers Heerspink, Hiddo J
Affiliation: Melbourne Renal Research Group, Royal Melbourne Hospital, Nephrology and Austin Hospital, Nephrology, Melbourne, Australia
Issue Date: 3-Nov-2011
Publication information: American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation 2011; 59(1): 75-83
Abstract: Previous studies have shown that patients with chronic kidney disease, including those with diabetic nephropathy, are more likely to die of cardiovascular disease than reach end-stage renal disease (ESRD). This analysis was conducted to determine whether ESRD is a more common outcome than cardiovascular death in patients with type 2 diabetic nephropathy, significant proteinuria, and decreased kidney function who were selected for participation in a clinical trial.Retrospective analysis of the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database derived from 2 prospective randomized controlled clinical trials (IDNT [Irbesartan Diabetic Nephropathy Trial] and RENAAL [Reduction of Endpoints in Non-Insulin-dependent Diabetes With the Angiotensin II Antagonist Losartan]).3,228 adult patients with type 2 diabetic nephropathy from IDNT and RENAAL were combined to establish the DIAMETRIC database. This is the largest global source of clinical information for patients with type 2 diabetic nephropathy who have decreased kidney function and significant proteinuria.Angiotensin receptor blocker versus non-angiotensin receptor blocker therapy to slow the progression of type 2 diabetic nephropathy (in the prospective trials).Incidence rates of ESRD, cardiovascular death, and all-cause mortality.Mean follow-up was 2.8 years; 19.5% of patients developed ESRD, approximately 2.5 times the incidence of cardiovascular death and 1.5 times the incidence of all-cause mortality. ESRD was more common than cardiovascular death in all subgroups analyzed with the exception of participants with low levels of albuminuria (albumin excretion <1.0 g/g) and well-preserved levels of kidney function (estimated glomerular filtration rate >45 mL/min/1.73 m(2)) at baseline.All participants were included in a prospective clinical trial.Patients with type 2 diabetic nephropathy, characterized by decreased kidney function and significant proteinuria, are more likely to reach ESRD than die during 3 years' mean follow-up. Given the rapidly increasing number of cases of type 2 diabetes worldwide, this has implications for predicting future renal replacement therapy requirements.
Gov't Doc #: 22051245
URI: https://ahro.austin.org.au/austinjspui/handle/1/11364
DOI: 10.1053/j.ajkd.2011.09.017
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
URL: https://pubmed.ncbi.nlm.nih.gov/22051245
Type: Journal Article
Subjects: Cardiovascular Diseases.etiology.mortality
Databases, Factual
Diabetes Mellitus, Type 2.complications
Diabetic Nephropathies.complications
Female
Humans
Incidence
Kidney Failure, Chronic.epidemiology.etiology
Male
Middle Aged
Proteinuria.complications
Retrospective Studies
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on May 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.